Eupraxia Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $37,923,793.
Profit Margin
| 2017 | 0 | -4.31M | |
|---|---|---|---|
| 2018 | 0 | -13.23M | |
| 2019 | 0 | -7.17M | |
| 2020 | 0 | -3.99M | |
| 2021 | 0 | -22.98M | |
| 2022 | 0 | -23.25M | |
| 2023 | 0 | -37.39M |
EPRX.TO Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 209.91K | 193.27K | 111.52K | 116.80K | 201.93K | 0 | 85.37K |
Gross profit | -209.91K | -193.27K | -111.52K | -116.80K | -201.93K | 0 | -85.37K |
Operating exp. | |||||||
Research and development | 27.54M | 17.20M | 9.67M | 859.78K | 2.94M | 6.64M | 3.18M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 37.92M | 23.20M | 18.67M | 2.24M | 6.15M | 14.31M | 4.97M |
Operating income | -36.89M | -22.63M | -20.87M | -2.24M | -6.14M | -14.31M | -4.97M |
Other income (expenses), net | -2.28M | 305.75K | -3.46M | -1.76M | 369.69K | -377.22K | -143.13K |
Income before tax | -39.18M | -23.91M | -23.36M | -4.01M | -7.24M | -14.83M | -4.99M |
Income tax expense | -89.66K | 930.51K | -1.34M | 1.86M | 1.39M | -1.45M | -627.56K |
Net income | -37.39M | -23.25M | -22.98M | -3.99M | -7.17M | -13.23M | -4.31M |
Earnings per share | |||||||
Basic EPS | -1.58 | -1.21 | -1.61 | -0.31 | -0.56 | -1.03 | -0.34 |
Diluted EPS | -1.58 | -1.21 | -1.61 | -0.31 | -0.56 | -1.03 | -0.34 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |